doi: 10.1038/414813a.
Biochemistry and molecular cell biology of diabetic complications
Affiliations
- PMID: 11742414
- DOI: 10.1038/414813a
Item in Clipboard
Biochemistry and molecular cell biology of diabetic complications
Nature.
.
Abstract
Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation. Four main molecular mechanisms have been implicated in glucose-mediated vascular damage. All seem to reflect a single hyperglycaemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain. This integrating paradigm provides a new conceptual framework for future research and drug discovery.
Similar articles
-
[Role of hyperglycemia in the development of diabetic microangiopathy].Nihon Rinsho. 2005 Jun;63 Suppl 6:45-51. Nihon Rinsho. 2005. PMID: 15999684 Review. Japanese. No abstract available.
-
Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.Int J Clin Pharmacol Res. 2003;23(4):129-34. Int J Clin Pharmacol Res. 2003. PMID: 15224502 Review.
-
Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.Diabetes Care. 1999 Mar;22 Suppl 2:B65-71. Diabetes Care. 1999. PMID: 10097902 Review.
-
[Role of oxidative stress in diabetic vascular complications].Fukuoka Igaku Zasshi. 2008 Mar;99(3):47-55. Fukuoka Igaku Zasshi. 2008. PMID: 18536327 Review. Japanese. No abstract available.
-
[Hyperglycemia and atherosclerosis].Journ Annu Diabetol Hotel Dieu. 2000:107-12. Journ Annu Diabetol Hotel Dieu. 2000. PMID: 10932873 Review. French. No abstract available.
Cited by
-
Investigating the mechanism of supraspinatus tendinopathy induced by type 2 diabetes mellitus in rats using un_targeted metabolomics analysis.BMC Musculoskelet Disord. 2024 Nov 18;25(1):920. doi: 10.1186/s12891-024-08061-1. BMC Musculoskelet Disord. 2024. PMID: 39558291 Free PMC article.
-
The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus.J Inflamm Res. 2024 Nov 9;17:8543-8554. doi: 10.2147/JIR.S492115. eCollection 2024. J Inflamm Res. 2024. PMID: 39539725 Free PMC article. Review.
-
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases.ACS Pharmacol Transl Sci. 2024 Oct 16;7(11):3279-3298. doi: 10.1021/acsptsci.4c00240. eCollection 2024 Nov 8. ACS Pharmacol Transl Sci. 2024. PMID: 39539254 Review.
-
Diabetic Peripheral Neuropathy and Glycemia Risk Index in Type 2 Diabetes: A Cross-Sectional Study.Diabetes Metab Syndr Obes. 2024 Nov 6;17:4191-4198. doi: 10.2147/DMSO.S482824. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39526203 Free PMC article.
-
Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights.Int J Retina Vitreous. 2024 Oct 28;10(1):83. doi: 10.1186/s40942-024-00603-y. Int J Retina Vitreous. 2024. PMID: 39468614 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
